Metropolis Healthcare Limited (BOM:542650)
India · Delayed Price · Currency is INR 543.55
+7.75 (1.45%)
At close: Jun 4, 2026
Metropolis Healthcare Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Metropolis Healthcare stock has a consensus rating of "Buy" and an average price target of ₹608.60. The average 1-year stock price forecast is 11.97% higher than the current stock price, while the lowest is ₹500.00 (-8.01%) and the highest is ₹715.00 (+31.54%).
Price Target: ₹608.60 (+11.97%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Metropolis Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 10 | 10 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 3 | 3 | 2 | 2 | 2 | 2 |
| Total | 19 | 19 | 18 | 18 | 18 | 18 |
Financial Forecast
Revenue This Year
18.95B
from 16.46B
Increased by 15.12%
Revenue Next Year
21.59B
from 18.95B
Increased by 13.94%
EPS This Year
12.21
from 9.51
Increased by 28.36%
EPS Next Year
15.16
from 12.21
Increased by 24.17%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 19.6B | ||
| Avg | 18.9B | ||
| Low | 18.6B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 19.4% | ||
| Avg | 15.1% | ||
| Low | 13.0% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 12.21 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 28.4% | ||
| Low | - |